Instalab
logoInstalab

Hemoglobin D

Find out whether you carry an inherited blood variant that can quietly shape your children's health.
4.8 (4,999 reviews)
Physician-reviewed results
How it works
Order from Instalab
No prescription or your own doctor's order needed
Get blood drawn
At home
Get results
Explained with clear next steps, no medical jargon

Should you take a Hemoglobin D test?

This test is most useful if any of these apply to you.

Planning to Start a Family
If you or your partner may carry a hemoglobin variant, knowing your status before pregnancy lets you plan rather than react.
Family History of Blood Disorders
If a relative has sickle cell, thalassemia, or another inherited anemia, this test clarifies whether you carry a variant of your own.
Unexplained Microcytic Anemia
If your red cells are small and iron supplements have not fixed the picture, an inherited hemoglobin variant may be the missing piece.
Ancestry From High-Prevalence Regions
If your family comes from Punjab or surrounding areas of South Asia, your baseline likelihood of carrying this variant is meaningfully higher.

About Hemoglobin D

You can carry HbD (hemoglobin D) for your entire life and never know it. Most carriers feel healthy, have normal blood counts, and learn about it only when a routine test happens to look at the structure of their hemoglobin. The variant itself rarely causes problems.

What changes that picture is what your partner carries. When HbD pairs with sickle hemoglobin or with a thalassemia gene in a child, the result can look like sickle cell disease or a serious anemia. Knowing your status before you start a family is the entire point of testing.

What Hemoglobin D Actually Is

Hemoglobin is the protein inside your red blood cells that carries oxygen. It is built from four protein chains, two from one gene family and two from another. A small change in one of those genes can produce a slightly different version of the protein, called a structural variant. HbD is one of these variants, and the most common form worldwide is Hb D-Punjab.

Because the change is in your DNA, your HbD status is fixed at conception and stays the same throughout your life. There is nothing you can do or take to change whether you carry it. The test is a one-time question: do you have this variant, and if so, in what combination?

Geographic and Ancestral Patterns

HbD is not evenly distributed across populations. It appears at roughly 2% frequency in the Punjab region of Northwest India, and Hb D-Punjab has been described as the most common hemoglobin variant in Sindh, Pakistan, where 2.1% of people referred for hemoglobinopathy testing carried it. In a newborn screening cohort in Manaus, Brazil, about 0.73% of babies were heterozygous carriers. Because the variant has spread through migration, it now appears in many countries even where the underlying ancestry is not obvious.

What Your Result Means

The clinical meaning of an HbD result depends almost entirely on whether you have one copy, two copies, or one copy paired with a different variant. Think of it as a genotype readout, not a number to optimize.

GenotypeWhat It Looks LikeWhat It Means
One copy of HbD (heterozygous trait)Roughly 30 to 45 percent HbD on testing, balanced with normal hemoglobinConsidered clinically silent. Carriers are usually identified incidentally and have no anemia or symptoms.
Two copies of HbD (homozygous)Predominantly HbD, very little normal adult hemoglobinNot typically associated with significant blood or clinical problems. Most people remain healthy.
HbD with beta-thalassemiaHbD plus a reduced-production gene from the other parentCan cause microcytosis (small red blood cells) and anemia. Severity depends on which thalassemia mutation is inherited.
HbD with HbS (sickle hemoglobin)HbD paired with the sickle variantDescribed as the most severe combination, producing manifestations similar to sickle cell anemia. Couples at risk should receive counseling.

Source: Tashfeen et al. 2025 (PLOS One); Huits et al. 2022 (J Clin Pathol).

Why One Reading Usually Settles It

Unlike cholesterol or blood sugar, this is not a number that drifts with diet, age, or season. Your HbD genotype is set at birth, so a single accurate test gives you a definitive answer. Repeat testing only makes sense if the first result was ambiguous, if you have had a recent blood transfusion that could dilute the readout, or if a clinician wants molecular confirmation of an unusual pattern.

What does change over time is the context around the result. If you find out you carry HbD in your twenties, the practical question shifts when you partner with someone who may also carry a hemoglobin variant. The reading itself stays the same. The decision pathway evolves.

When Results Can Be Misleading

  • Confusion with sickle hemoglobin on alkaline electrophoresis: Hb D-Punjab migrates with HbS at alkaline pH and with normal hemoglobin at acidic pH. Without a confirmatory method, a lab can miscall HbD as HbS, which is why HPLC (high-performance liquid chromatography), capillary electrophoresis, or genetic testing is used to settle the diagnosis.
  • Recent blood transfusion: A transfusion within the previous few months adds donor hemoglobin to your circulation and dilutes the apparent percentage of your own variant. Testing should be deferred until the donor red cells have cleared.
  • Co-existing iron deficiency or thalassemia: Both can lower hemoglobin and shift red cell indices, making it harder to interpret whether anemia is from the variant, from low iron, or from both. Iron studies are usually run alongside.
  • Atypical or rare variants: A pattern that looks like HbD on chromatography can occasionally turn out to be a different rare variant. If the picture does not fit cleanly, molecular confirmation by HBB gene sequencing is the deciding test.

What an Abnormal Result Should Make You Do

If your result shows HbD, the most useful next steps depend on what the pattern looks like and what you are planning.

  • Confirm the genotype. If your lab used HPLC or electrophoresis alone, ask whether HBB gene sequencing is needed. This is the test that distinguishes HbD-Punjab from rarer look-alike variants and confirms whether you are heterozygous or homozygous.
  • Get your partner tested before pregnancy. The combinations that matter clinically are HbD with HbS or HbD with beta-thalassemia. Partner screening with a hemoglobin electrophoresis is the single most useful follow-up if you are planning a family.
  • Run iron studies if you have anemia. If your hemoglobin or red cell size is low, ferritin and a CBC (complete blood count) help separate iron deficiency from a co-inherited thalassemia. Treating iron deficiency does not change your HbD status, but it can dramatically improve how you feel.
  • Consider genetic counseling. This is especially valuable if you are planning a pregnancy, if your partner also carries a hemoglobin variant, or if you have a family history of unexplained anemia or sickle disease. A counselor can walk through inheritance probabilities and prenatal options.

Why Standard Labs Can Miss This

A routine CBC measures how much hemoglobin you have and how big your red cells are. It does not tell you what kind of hemoglobin you are making. Standard iron and ferritin tests can flag anemia but cannot identify a structural variant. Detecting HbD requires a test that looks at the protein itself, either by chromatography, electrophoresis, or, increasingly, by proteomics methods that can classify multiple variants in one assay with very high accuracy.

This is why people with ancestry from high-prevalence regions, or with unexplained microcytic anemia that does not respond to iron, are often the ones who finally get a hemoglobin variant test ordered. The information was always there. It just was not being asked for.

Frequently Asked Questions

References

8 studies
  1. Brito RS, Barros LML, Moreira LW, Normando RN, De Jesus TPB, Goncalves MS, Ramasawmy R, Oliveira SF, Silva KER, Fraiji N, Hora LF, Netto RLA, Moura Neto JPBMC Pregnancy and Childbirth2022
  2. Huits R, Feyens a, Lonneville N, Peyrassol X, Adam AS, Gulbis B, Van Esbroeck MJournal of Clinical Pathology2022
  3. Wei S, Nielsen a, Helby J, Drici L, Rasmussen C, Wang J, Mann M, Petersen J, Wewer Albrechtsen NJ, Glenthoj aHemasphere2025